false
OasisLMS
Login
Catalog
Pregnancy and Women's SUD: Focus on OUD Treatment ...
Pregnancy and Women's SUD: Focus on OUD Treatment ...
Pregnancy and Women's SUD: Focus on OUD Treatment Strategies Recording
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Tipu Khan delivered a comprehensive lecture on opioid use disorder (OUD) in pregnancy, while also reviewing alcohol, benzodiazepine, nicotine, vaping, and cannabis use. He emphasized that pregnancy involves a mother-infant dyad, so treatment must address both maternal health and fetal development, with attention to stigma, trauma, and social instability. Key points included: - <strong>Screening</strong> for substance use is recommended at the first prenatal visit and again each trimester if risk factors persist. - <strong>Medication treatment for OUD (MOUD)</strong> with <strong>methadone or buprenorphine</strong> is preferred over withdrawal/detoxification, which can increase relapse and fetal risk. - <strong>Buprenorphine and methadone are both effective</strong>, but buprenorphine may lead to less severe neonatal opioid withdrawal and shorter infant hospital stays. - <strong>Dose changes in pregnancy</strong> are often needed, especially for methadone in the third trimester; doses should generally <strong>not be reduced immediately after delivery</strong>. - <strong>High-dose fentanyl</strong> may require newer induction strategies, including <strong>microinduction, rapid induction, macroinduction, IV buprenorphine, and direct-to-inject long-acting buprenorphine</strong>. Where treatment is started depends on patient stability and support: home, clinic, residential care, or hospital. - He reviewed management of <strong>precipitated withdrawal</strong>, pain control during labor and postpartum, and the importance of a prewritten birth plan. - <strong>Breastfeeding is usually encouraged</strong> with methadone or buprenorphine, and is generally compatible with many other medications, with specific cautions for codeine, illicit stimulants, and certain situations involving HIV or hepatitis C. Overall, he stressed compassionate, evidence-based, patient-centered care to improve outcomes for both parent and infant.
Keywords
opioid use disorder
pregnancy
methadone
buprenorphine
medication treatment
neonatal opioid withdrawal
substance use screening
fentanyl induction
precipitated withdrawal
breastfeeding
maternal fetal health
patient-centered care
×
Please select your language
1
English